Literature DB >> 1431306

Interferon-alpha suppresses the capacity of T cells to help antibody production by human B cells.

V Brinkmann1, C H Heusser, J Baer, E Kilchherr, F Erard.   

Abstract

This study was designed to analyze the effect of interferon-alpha (IFN-alpha) on the potential of T cells to help B-cell differentiation in vitro. Human splenic T cells preactivated via the T-cell receptor (TCR)/CD3 complex, as well as murine EL4 thymoma T cells preactivated with phorbol esters, stimulated human B cells via a species cross-reactive physical interaction to differentiate into antibody-producing cells. If the human or murine T cells were activated in the presence of IFN-alpha, normal proliferation and interleukin-2 (IL-2) production occurred, but the cells did not acquire any B-cell helper potential. Therefore, IFN-alpha modulates the B-cell stimulatory potential of T cells by interfering with the T-cell activation process. In contrast, IFN-alpha neither acted on B cells directly nor on already activated T cells, because it did not suppress B-cell differentiation induced by T cells preactivated in the absence of IFN-alpha. IFN-alpha did not induce the production of inhibitory T-cell factor(s), since T cells preactivated in the presence of IFN-alpha did not inhibit the interaction of B cells with T cells optimally preactivated in the absence of IFN-alpha. Taken together the data indicate that IFN-alpha suppresses the potential of T cells to stimulate B-cell differentiation by interfering with the T-cell activation process, but acts neither on B cells directly nor on already activated T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431306     DOI: 10.1089/jir.1992.12.267

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  7 in total

1.  Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity.

Authors:  Y Luo; X Chen; R Han; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Study of recombinant human IFN-α-2b bacilli calmette-guerin activated killer cells and against bladder cancer cell in vitro.

Authors:  Xiaodong Fan; Ruifa Han
Journal:  Front Med China       Date:  2007-10

Review 3.  Interferon-alpha and its effects on post-transplant lymphoproliferative disorders.

Authors:  A Faro
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.

Authors:  P J Simons; R A Oostendorp; M P Tas; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

5.  IgG4-Related Fibrotic Diseases from an Immunological Perspective: Regulators out of Control?

Authors:  Laura C Lighaam; Rob C Aalberse; Theo Rispens
Journal:  Int J Rheumatol       Date:  2012-06-04

6.  Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.

Authors:  V Brinkmann; T Geiger; S Alkan; C H Heusser
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

7.  Th2 cells and cytokine networks in allergic inflammation of the lung.

Authors:  A J Coyle; S Tsuyuki
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.